A federal research body that dismissed a controversial multiple-sclerosis treatment as totally unproven likely undermined its credibility by failing to seek advice from the public and supporters of the therapy, two prominent medical scientists suggest.

The researchers at Toronto's St. Michael's Hospital say the Canadian Institutes of Health Research should reach out to ordinary lay people -- not just scientists -- when pondering such emotional medical issues in future.

A critique from Drs. Andreas Laupacis and Arthur Slutsky in the journal Open Medicine also hints that it might have been worthwhile for the institute to fund a trial of the MS treatment developed by Dr. Paulo Zamboni -- even if the science did not justify doing so................. [Read More]